ENDRA Life Sciences Inc.
NDRA
$6.46
$1.1922.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 112.19% | 58.62% | -98.57% | -30.19% | -18.30% |
| Total Depreciation and Amortization | -1.26% | 0.51% | 0.25% | 20.12% | -28.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -308.45% | -118.53% | 276.65% | 1,443.07% | 108.20% |
| Change in Net Operating Assets | -89.15% | 1,400.59% | -74.23% | -136.74% | 128.57% |
| Cash from Operations | 17.16% | 30.53% | -38.46% | -4.52% | 13.87% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 396.84% | 115.00% | -- | -- | -- |
| Cash from Investing | 392.69% | 115.00% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,376.64% | -94.24% | 2,963.55% | -82.56% | 488.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,376.64% | -94.24% | 2,963.55% | -82.56% | 488.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,377.04% | -1,180.44% | 96.88% | -295.83% | 77.99% |